Description

1. Product Overview: Udiliva 150® is a bile acid formulation containing Ursodeoxycholic Acid, used for the treatment of cholestatic liver diseases and gallstone-related conditions.

2. Composition: Ursodeoxycholic Acid BP 150 mg | Dosage Form: Tablet

3. Pharmacological Class: Bile Acid / Hepatoprotective Agent

4. Mechanism of Action: Ursodeoxycholic Acid reduces cholesterol absorption and secretion in bile, decreases bile cholesterol saturation, improves bile flow, and protects liver cells from toxic bile acids.

5. Indications: Gallstone dissolution (cholesterol stones) | Primary biliary cholangitis | Cholestatic liver diseases | Liver function support in selected conditions

6. Dosage & Administration: As directed by physician only | Oral use | Usually taken in divided doses with food | Duration depends on clinical condition

7. Clinical Benefits: Improves bile flow | Helps dissolve cholesterol gallstones | Protects liver cells | Supports improved liver function

8. Contraindications: Hypersensitivity to Ursodeoxycholic Acid or any component of the formulation | Calcified gallstones | Complete biliary obstruction

9. Precautions: Regular liver function monitoring required | Use cautiously in advanced liver disease | Long-term therapy may be required for gallstone dissolution

10. Drug Interactions: May interact with aluminum-containing antacids | May reduce absorption of certain lipid-lowering agents

11. Special Populations: Use in pregnancy only if clearly necessary and prescribed | Use in lactation and elderly under medical supervision

12. Adverse Effects: Diarrhea | Abdominal discomfort | Nausea | Rare elevation of liver enzymes

13. Storage Conditions: Store below 30°C | Protect from light and moisture | Keep out of reach of children

14. Packaging: Tablet blister pack

15. Manufacturer: Everest Pharmaceutical Ltd.